Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. - Wikidata - wikimedia - TriplyDB

Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

http://www.wikidata.org/entity/Q36889954

about

Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria Why is Pseudomonas aeruginosa a pathogen?Evaluation of a microarray-hybridization based method applicable for discovery of single nucleotide polymorphisms (SNPs) in the Pseudomonas aeruginosa genome Shanghai fever: a distinct Pseudomonas aeruginosa enteric disease.Mutations in the Pseudomonas aeruginosa needle protein gene pscF confer resistance to phenoxyacetamide inhibitors of the type III secretion system.Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes Management of Pseudomonas aeruginosa pneumonia: one size does not fit all Pathogenicity islands PAPI-1 and PAPI-2 contribute individually and synergistically to the virulence of Pseudomonas aeruginosa strain PA14 Correlation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa.Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.The ability of virulence factor expression by Pseudomonas aeruginosa to predict clinical disease in hospitalized patients Synthesis and structure-activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS).Innate immune responses to Pseudomonas aeruginosa infection.Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.Visualizing the Mechanism of Epoxide Hydrolysis by the Bacterial Virulence Enzyme Cif.Bacterial and clinical characteristics of health care- and community-acquired bloodstream infections due to Pseudomonas aeruginosa.N-3-(oxododecanoyl)-L-homoserine lactone promotes the induction of regulatory T-cells by preventing human dendritic cell maturation.Fitness Cost of Fluoroquinolone Resistance in Clinical Isolates of Pseudomonas aeruginosa Differs by Type III Secretion Genotype.Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells Matrix metalloproteases in bronchoalveolar lavage fluid of patients with type III Pseudomonas aeruginosa pneumonia.The type III secretion system of Pseudomonas aeruginosa: infection by injection.Pseudomonas aeruginosa virulence and antimicrobial resistance: two sides of the same coin?Update on the treatment of Pseudomonas aeruginosa pneumonia.Emerging themes of cAMP regulation of the pulmonary endothelial barrier.Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens.Structure and function of the Type III secretion system of Pseudomonas aeruginosa.Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation.Molecular Detection of the Virulent ExoU Genotype of Pseudomonas aeruginosa Isolated from Infected Surgical Incisions.Recently published papers: Pseudomonas, brain and bowel injury and novel cardiac therapies Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients.Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii.Ventilator-associated pneumonia caused by Pseudomonas aeruginosa: cap your needles!An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity.Pseudomonas aeruginosa: so many virulence factors, so little time.Pseudomonas aeruginosa: an uninvited guest refuses to leave.PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice.Increased claudin-3, -4 and -18 levels in bronchoalveolar lavage fluid reflect severity of acute lung injury.

P2860

Q27346512-DA957D96-6BC5-4B1C-938E-21D7AE82DC7B Q30408273-ADE5EBC3-6754-4904-9DAC-F4E2C839064D Q30431366-9A7122D0-9FAA-403B-8CA3-EF4018C9D8A4 Q30434529-B48767CE-BB24-4E7C-AD88-CCF840B1F66A Q33400850-392B9A70-E3CD-4C40-ACF0-F42741D583BD Q33409776-50166E4E-2A2A-4D0D-903D-5E7B80226651 Q33622815-802AE0DA-7EC4-4162-8CDF-8934718EE28D Q33754176-E3CD4C30-BD2D-4AA9-9F83-25BED0BFCD0C Q33754588-9EDB2F10-F549-463A-8578-3C08421DA659 Q33769060-4143E922-7F05-465E-A5CE-D628D972D392 Q33807598-4D4023E8-C404-423C-AF70-31DC2989952E Q34384649-200C7863-93F0-492A-A3CB-E99C6AA03544 Q34478058-F5137FB7-994A-4034-A07B-FB604D6CDC71 Q35118409-7216AE68-0539-4BB3-9AFC-75103420A5E0 Q35566398-45EAE741-6D95-4CF4-9AA0-AA285283F20C Q35783999-F1C2CAB7-0F0E-41D5-AB83-732251C1678B Q36614104-71B49003-3F8D-476D-874E-0D2B06EC0C1C Q37036553-0B25379F-B245-4032-9D4C-B5F0580D7DBA Q37071542-EE539536-2A99-45ED-8AE3-DFBB3BDB1700 Q37306380-C2816C7C-BC07-4665-9040-F2D3994A675C Q37358382-E91D0B70-2D8A-46ED-9D14-347089D13317 Q37372512-9F43E1B8-1809-45BF-8037-B618CFBE5D9D Q37373550-CF255B27-7BB6-45E2-9BAF-F6B448B1F5F9 Q37397923-C3523DB2-7DC8-44D4-A3DE-870EFF8AFA68 Q37402651-C57AE88C-1957-4D7B-8D06-0E2054650568 Q37516904-39A674CE-A168-433D-888A-5E049EDD3F05 Q37845025-F159968C-4C83-4EC9-A9A5-6E46501020C6 Q38058355-C6068DC1-A353-4C38-A6BC-61F9670D8CD7 Q38072996-9674E7E0-39D4-49B0-9712-5C99F50F3D49 Q38210320-1C3E2684-B980-4C64-98D6-2CF35AD7CD09 Q40605168-B7B51645-05D2-4945-BA56-D369E00BB731 Q41399311-B2AD2BDA-EA98-49D3-8287-1039F4CEBD9F Q42276769-3D555423-DA2A-48F3-8BE2-3F001EADD9D1 Q42287771-6912C2AF-A07A-4C80-8415-CE3B2CC5DD1E Q42855404-D0EA3D16-10D9-4A92-8529-59009AD82FB8 Q42906503-E8EB63A7-3573-4B9A-A169-87AE8334E949 Q43181958-708EE4FD-3C98-41C0-A490-6B11F2BCF1F1 Q43446661-71243614-1F35-4A80-B262-C27A031B7540 Q43472217-8CCB9FAA-8CE1-428C-8F0B-396A018309CE Q44228192-79810A88-DF16-480B-B271-57299949400E

P2860

Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

http://www.wikidata.org/entity/Q36889954

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

@en

type

label

Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

@en

prefLabel

Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

@en

P1433

Q36889954-CEA255C8-8F26-44B5-B730-BF863FC60C37

P1476

Q36889954-21BAFD7F-D48B-4668-AB07-27AEE143CC2A

P2093

Q36889954-5A1FA224-8CC5-4CE6-94BF-A3DE5DD00F7C

Q36889954-80EE80FE-2F4F-417D-AB3F-BCF556246E85

Q36889954-8F358ABB-2186-4BE1-8720-7F0ED68A1776

Q36889954-B0D4B197-E5CB-402B-AEE7-A64F44244986

Q36889954-F8FAFA0D-DDA9-4D9E-9B74-88EE98CF93DB

Q36889954-FCCAEC4A-F863-47EE-B618-F406D273555F

P2860

Q36889954-00A4AEF2-AF24-4A67-8F5A-5743FA2B4ABB

Q36889954-03DA0668-ECCB-44C3-BD14-6CF25A2CF403

Q36889954-12C62731-CEAF-4E85-B986-0DA639F5965A

Q36889954-12D03FE2-9A83-4EEB-97D3-4CFB3DBAF1EA

Q36889954-1AB6DC8A-C2BA-451F-9063-35406761ED28

Q36889954-1DABABF3-CAA1-410D-B014-CB7E8A056C80

Q36889954-225BA90E-5846-43F4-9E12-640A823B7A59

Q36889954-24ABB144-DDF7-42CF-B45D-F061A66B69F4

Q36889954-314F88A7-7609-434D-8007-71B6C1B56D92

Q36889954-39CB7282-5A41-4B04-A52B-B55CCEE5F1FC

P304

Q36889954-9DA18651-5852-4DF8-A1A7-30EE195D589E

P31

Q36889954-0F4735AA-FAE4-4117-85DC-C49DE02EC832

P356

Q36889954-A7BBC896-CF87-4854-95E7-4B7917D222F1

P407

Q36889954-C1E49702-AC50-4133-9FE6-EB4F9B6B7830

P433

Q36889954-25B1DFD4-07E4-4AD4-A84D-45E08A100964

P478

Q36889954-1A9C5F88-BB1A-448B-9C5D-8416D7F35FDC

P577

Q36889954-D5019982-4B86-457F-A11C-48D3B7920B13

P698

Q36889954-163E32ED-EAF3-465A-B0D4-8313FEFE0966

P921

Q36889954-1EC7C433-F471-4E69-B491-A621856F423D

Q36889954-4307944A-9BE8-4F50-8DFD-D998A4B8EBB1

Q36889954-4C9C3397-23AC-434E-8FBB-CED77FE4E462

P932

Q36889954-C7E75F09-8575-4175-9A42-DF160271B543

P356

RCCM.200802-239OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

@en

P2093

Ali A El Solh

http://www.w3.org/2001/XMLSchema#string

Jeanine P Wiener-Kronish

http://www.w3.org/2001/XMLSchema#string

Kristie Szarpa

http://www.w3.org/2001/XMLSchema#string

Lilibeth A Pineda

http://www.w3.org/2001/XMLSchema#string

Morohunfolu E Akinnusi

http://www.w3.org/2001/XMLSchema#string

Susan V Lynch

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Type III protein secretion systems in bacterial pathogens of animals and plants

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes

Measurement of protein using bicinchoninic acid

Ventilator-associated pneumonia

Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway

APACHE II: a severity of disease classification system

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.

P304

513-519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200802-239OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18467510

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

2542430

http://www.w3.org/2001/XMLSchema#string